PHK
APLS

Point72 Hong Kong’s Apellis Pharmaceuticals APLS Stock Holding History

Point72 Hong Kong’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$859K Buy
+37,941
New +$885K 0.04% 227
2022
Q4 		– Sell
-950
Closed -$65K – 160
2022
Q3 		$65K Buy
+950
New +$56.2K ﹤0.01% 1347
2022
Q2 		– Sell
-4,181
Closed -$212K – 1894
2022
Q1 		$212K Buy
4,181
+3,420
+449% +$151K 0.01% 948
2021
Q4 		$36K Sell
761
-8,218
-92% -$324K ﹤0.01% 1421
2021
Q3 		$296K Buy
8,979
+2,922
+48% +$164K 0.01% 1068
2021
Q2 		$383K Buy
+6,057
New +$313K 0.01% 992
2020
Q4 		– Sell
-436
Closed -$13K – 1697
2020
Q3 		$13K Sell
436
-894
-67% -$26.7K ﹤0.01% 947
2020
Q2 		$43K Buy
1,330
+214
+19% +$6.87K ﹤0.01% 761
2020
Q1 		$30K Buy
+1,116
New +$39.6K 0.01% 458
2019
Q4 		– Sell
-40
Closed -$1K – 1138
2019
Q3 		$1K Buy
+40
New +$1.1K ﹤0.01% 889
2019
Q2 		– Sell
-137
Closed -$3K – 1106
2019
Q1 		$3K Sell
137
-99
-42% -$1.56K ﹤0.01% 854
2018
Q4 		$3K Buy
+236
New +$3.62K ﹤0.01% 682

Other funds holding APLS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Hong Kong's APLS Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Apellis Pharmaceuticals (APLS) in Q3 2025: 37,941 shares worth $859K. The stake represents 0.04% of the portfolio and ranks #227 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in APLS as recently as Q3 2022.

Point72 Hong Kong first reported a position in APLS in Q4 2018 and has held it in 12 quarters since. 273 funds tracked by Wall St. Rank hold APLS as of Q3 2025.

  • Point72 Hong Kong held 37,941 shares of Apellis Pharmaceuticals worth $859K as of Q3 2025.
  • Apellis Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
  • Apellis Pharmaceuticals made up 0.04% of Point72 Hong Kong's portfolio in Q3 2025, its #227 holding.
  • Point72 Hong Kong first reported a position in Apellis Pharmaceuticals in Q4 2018 and has held it in 12 quarters since.
  • 273 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.